Company / Current Liabilities per Share
Seres Therapeutics, Inc. Current Liabilities per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.23
FY2025
5-year range
$0.66 / $2.23
FY2021-FY2025
Trend
+226.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +227% YoY in FY2025, a notable deviation from the 9-year average annual change of +21%.
Based on SEC 10-K filings.
2.23 in FY2025 with a 10-year CAGR of +3.5%.
Increased from $0.93 to $2.23 over the past 3 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +33.8%
- 5-Year CAGR
- +27.5%
- 10-Year CAGR
- +3.5%
Key checks
Key Insights
- In FY2025, current liabilities per share increased 226.8% year-over-year.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.23 | +226.8% |
| FY2023 | $0.68 | -26.6% |
| FY2022 | $0.93 | +3.6% |
| FY2021 | $0.90 | +35.9% |
| FY2020 | $0.66 | -41.1% |
| FY2019 | $1.12 | +8.4% |
| FY2018 | $1.04 | +32.2% |
| FY2017 | $0.78 | +0.6% |
| FY2016 | $0.78 | -50.8% |
| FY2015 | $1.58 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026